140 related articles for article (PubMed ID: 18366304)
1. KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
Chou CC; Lunn CA; Murgolo NJ
Expert Rev Mol Diagn; 2008 Mar; 8(2):179-87. PubMed ID: 18366304
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
4. KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation.
Shepherd MC; Duffy SM; Harris T; Cruse G; Schuliga M; Brightling CE; Neylon CB; Bradding P; Stewart AG
Am J Respir Cell Mol Biol; 2007 Nov; 37(5):525-31. PubMed ID: 17585114
[TBL] [Abstract][Full Text] [Related]
5. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice.
Reich EP; Cui L; Yang L; Pugliese-Sivo C; Golovko A; Petro M; Vassileva G; Chu I; Nomeir AA; Zhang LK; Liang X; Kozlowski JA; Narula SK; Zavodny PJ; Chou CC
Eur J Immunol; 2005 Apr; 35(4):1027-36. PubMed ID: 15770697
[TBL] [Abstract][Full Text] [Related]
6. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.
Ohya S; Niwa S; Kojima Y; Sasaki S; Sakuragi M; Kohri K; Imaizumi Y
J Pharmacol Exp Ther; 2011 Aug; 338(2):528-36. PubMed ID: 21602424
[TBL] [Abstract][Full Text] [Related]
7. K
Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
[TBL] [Abstract][Full Text] [Related]
8. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
Wölfle SE; Schmidt VJ; Hoyer J; Köhler R; de Wit C
Cardiovasc Res; 2009 Jun; 82(3):476-83. PubMed ID: 19218287
[TBL] [Abstract][Full Text] [Related]
9. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
Koshy S; Wu D; Hu X; Tajhya RB; Huq R; Khan FS; Pennington MW; Wulff H; Yotnda P; Beeton C
PLoS One; 2013; 8(10):e76740. PubMed ID: 24146918
[TBL] [Abstract][Full Text] [Related]
10. Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels.
Schmidt J; Friebel K; Schönherr R; Coppolino MG; Bosserhoff AK
Cell Res; 2010 Nov; 20(11):1224-38. PubMed ID: 20733613
[TBL] [Abstract][Full Text] [Related]
11. Intermediate conductance Ca2+-activated potassium channel (KCa3.1) in the inner mitochondrial membrane of human colon cancer cells.
De Marchi U; Sassi N; Fioretti B; Catacuzzeno L; Cereghetti GM; Szabò I; Zoratti M
Cell Calcium; 2009 May; 45(5):509-16. PubMed ID: 19406468
[TBL] [Abstract][Full Text] [Related]
12. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.
Lallet-Daher H; Roudbaraki M; Bavencoffe A; Mariot P; Gackière F; Bidaux G; Urbain R; Gosset P; Delcourt P; Fleurisse L; Slomianny C; Dewailly E; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
Oncogene; 2009 Apr; 28(15):1792-806. PubMed ID: 19270724
[TBL] [Abstract][Full Text] [Related]
13. KCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells.
Arthur GK; Duffy SM; Roach KM; Hirst RA; Shikotra A; Gaillard EA; Bradding P
PLoS One; 2015; 10(12):e0145259. PubMed ID: 26689552
[TBL] [Abstract][Full Text] [Related]
14. [Physiological Role of K(+) Channels in the Regulation of T Cell Function].
Ohya S
Yakugaku Zasshi; 2016; 136(3):479-83. PubMed ID: 26935090
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of water channel aquaporin-4 in experimental autoimmune encephalomyeritis.
Miyamoto K; Nagaosa N; Motoyama M; Kataoka K; Kusunoki S
J Neurol Sci; 2009 Jan; 276(1-2):103-7. PubMed ID: 18945445
[TBL] [Abstract][Full Text] [Related]
16. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury.
Malabanan KP; Kanellakis P; Bobik A; Khachigian LM
Circ Res; 2008 Aug; 103(4):378-87. PubMed ID: 18617696
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.
Varga Z; Csepany T; Papp F; Fabian A; Gogolak P; Toth A; Panyi G
Immunol Lett; 2009 Jun; 124(2):95-101. PubMed ID: 19409928
[TBL] [Abstract][Full Text] [Related]
18. Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.
McNaughton-Smith GA; Burns JF; Stocker JW; Rigdon GC; Creech C; Arrington S; Shelton T; de Franceschi L
J Med Chem; 2008 Feb; 51(4):976-82. PubMed ID: 18232633
[TBL] [Abstract][Full Text] [Related]
19. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
20. KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.
Brown BM; Pressley B; Wulff H
Curr Neuropharmacol; 2018; 16(5):618-626. PubMed ID: 28676010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
